MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Tomosynthesis Option for Mammography Platform Approved by FDA

By MedImaging International staff writers
Posted on 13 May 2015
Print article
Image: Siemens Healthcare’s MAMMOMAT Inspiration (Photo courtesy of Siemens Healthcare).
Image: Siemens Healthcare’s MAMMOMAT Inspiration (Photo courtesy of Siemens Healthcare).
The US Food and Drug Administration (FDA; Silver Spring, MD USA) has approved the breast tomosynthesis add-on for Siemens Healthcare (Erlangen, Germany) MAMMOMAT Inspiration digital mammography platforms.

The tomosynthesis algorithm creates an approximation of a 3-D image of the breast by reconstructing multiple 2-D breast images. The 3-D image enables detection of tumors that would otherwise be hidden by overlapping breast tissue, reduces false-positive findings, and allows more accurate diagnosis than standard 2-D digital mammography.

The MAMMOMAT acquires 25 two-dimensional images while moving through an angular range of 50 degrees around the breast. The Tomosynthesis algorithm uses the projections to generate a 3-D volume set and reconstructs them as 3-D Digital Breast Tomosynthesis (DBT) images. This helps clinicians assess the size and type of breast lesions and microcalcifications.

Gregory Sorensen, MD, president and CEO of Siemens Healthcare North America, said, “Our clinical data has demonstrated that the addition of Siemens’ digital breast tomosynthesis to a patient’s traditional 2-D digital mammogram increases detection of breast tumors. We know that in clinical practice, this increased diagnostic accuracy also means fewer diagnostic biopsy procedures and fewer anxiety-inducing recalls, which typically contributes to both improved patient outcomes and reduced cost.”

Related Links:

Siemens Healthcare


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
PACS Workstation
CHILI Web Viewer
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more